Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Debt Ratio: 2017-2021

Historic Debt Ratio for Sunshine Biopharma (SBFM) over the last 4 years, with Dec 2021 value amounting to 0.86.

  • Sunshine Biopharma's Debt Ratio fell 4.98% to 0.86 in Q4 2021 from the same period last year, while for Dec 2021 it was 3.29, marking a year-over-year increase of 262.34%. This contributed to the annual value of 0.86 for FY2021, which is 4.98% down from last year.
  • As of FY2021, Sunshine Biopharma's Debt Ratio stood at 0.86, which was down 4.98% from 0.91 recorded in FY2020.
  • Over the past 5 years, Sunshine Biopharma's Debt Ratio peaked at 0.91 during FY2020, and registered a low of 0.27 during FY2018.
  • In the last 2 years, Sunshine Biopharma's Debt Ratio had a median value of 0.89 in 2020 and averaged 0.89.
  • Data for Sunshine Biopharma's Debt Ratio shows a maximum YoY decreased of 12.46% (in 2018) over the last 5 years.
  • Over the past 4 years, Sunshine Biopharma's Debt Ratio (Yearly) stood at 0.31 in 2017, then declined by 12.46% to 0.27 in 2018, then reached 0.91 in 2020, then declined by 4.98% to 0.86 in 2021.